Investment

CVS voluntarily pulling decongestants from shelves that contain ineffective ingredient

1 Mins read

CVS Health Corp.
CVS,
-1.47%
is pulling decongestants off their shelves that contain an ingredient an Food and Drug Administration advisory committee determined did not work, according to a Thursday report from the Wall Street Journal. Used as a key ingredient in decongestants for nearly a century, FDA advisors in September determined that phenylephrine did not improve congestion. While the FDA has not made a decision on the ingredient, CVS said it is voluntarily taking products containing it off their shelves. CVS shares were last up 0.1% in recent activity.

Read the full article here

Related posts
Investment

Opinion: The top 10% of Americans are propping up the economy. Here’s what will happen if they stop spending. 

1 Mins read
Outside the Box The wealthy are spending, but many consumers are pulling back — and the stock market is fragile Last Updated:…
Investment

AMC’s most liquid bond is rallying following the movie-theater chain’s fourth-quarter results

1 Mins read
Published: Feb. 27, 2025 at 1:23 p.m. ET AMC Entertainment Holdings Inc.’s most liquid bond rallied this week, lifted by better-than-expected fourth-quarter revenue…
Investment

Okta delivers what some of its bigger peers couldn’t: a rosy outlook

1 Mins read
Last Updated: March 3, 2025 at 8:14 p.m. ETFirst Published: March 3, 2025 at 4:38 p.m. ET Not all software companies are giving upbeat…
Get The Latest News

Subscribe to get the top fintech and
finance news and updates.

Leave a Reply

Your email address will not be published. Required fields are marked *